FDA Import Refusal 799-9958177-2/10002/1 — SANTEN PHARMACEUTICAL
The FDA refused shipment 799-9958177-2/10002/1 from SANTEN PHARMACEUTICAL (Japan) on Nov 19, 2025. The refused product falls under Drugs and Biologics — NAPHAZOLINE HCL (ADRENERGIC). Cited charges: 118,3280 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Nov 19, 2025
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 60CBY46 NAPHAZOLINE HCL (ADRENERGIC)
- Charges
- 118,3280